MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajodo.2019.04.037

Медицинская библиотека · American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics · 2020

Alteration of tooth movement by reveromycin A in osteoprotegerin-deficient mice.

Minamoto Chisato, Miyazawa Ken, Tabuchi Masako, Hirano Miyuki, Mizuno Manami, Yoshizako Mamoru, Torii Yasuyoshi, Asano Yuichirou, Sato Takuma, Kawatani Makoto, Osada Hiroyuki, Maeda Hatsuhiko, Goto Shigemi

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Osteoprotegerin-deficient mice develop severe high-turnover osteoporosis with porous low-density trabecular bone from an age-related increase in osteoclast activity and are useful alveolar bone models of osteoporosis or frail periodontal tissue. Bisphosphonate (BP), a first-line drug for osteoporosis, is bone-avid, causing side effects such as brittle and fragile bones and jaw osteonecrosis after tooth extraction. In orthodontics, active movement is precisely controlled by temporarily suppressing and resuming movement. BP impedes such control because of its long half-life of several years in bone. Therefore, we investigated the novel osteoclast-specific inhibitor reveromycin A (RMA), which has a short half-life in bone. We hypothesized that tooth movement could be precisely controlled through temporary discontinuation and re-administration of RMA.

METHODS

Osteoprotegerin-deficient mice and wild-type mice were developed as tooth movement models under constant orthodontic force. A constant orthodontic force of 10 g was induced using a nickel-titanium closed coil spring to move the maxillary first molar for 14 days. We administered BP (1.25 mg/kg) or RMA (1.0 mg/kg) continuously and then discontinued it to reveal how the subsequent movement of teeth and surrounding alveolar bone was affected.

RESULTS

Continuous BP or RMA administration suppressed osteoclast activity and preserved alveolar bone around the roots, apparently normalizing bone metabolism. Tooth movement remained suppressed after BP discontinuation but resumed at a higher rate after discontinuation of RMA.

CONCLUSIONS

RMA appears useful for controlling orthodontic tooth movement because it can be suppressed and resumed through administration and discontinuation, respectively.

Для цитирования: Minamoto Chisato, Miyazawa Ken, Tabuchi Masako, Hirano Miyuki, Mizuno Manami, Yoshizako Mamoru, Torii Yasuyoshi, Asano Yuichirou, Sato Takuma, Kawatani Makoto, Osada Hiroyuki, Maeda Hatsuhiko, Goto Shigemi. Alteration of tooth movement by reveromycin A in osteoprotegerin-deficient mice.. American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics. 2020. DOI: 10.1016/j.ajodo.2019.04.037.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.